| http://www.w3.org/ns/prov#value | - You see here on the chart, Xarelto sales ascend strongly in all regions, particularly in Germany and the United States, following further product launches and indication expansions, particularly in SPAF. In addition, we received already encouraging early launch feedback on Stivarga and EYLEA. More product introductions lie ahead.
|
